Inventor · disambiguated record
Paul Wender
Also filed as: WENDER PAUL · WENDER PAUL A
37 granted patents·24 pending applications·1,595 citations·filing 1998–2024
98Inventor score
Top patents by PatentIndex Score
61 records- 0199US6306993B1Method and composition for enhancing transport across biological membranesUNIV LELAND STANFORD JUNIOR·Filed 1998·Granted Oct 23, 2001·361 cites·15 claims
- 0298US6495663B1Method and composition for enhancing transport across biological membranesUNIV LELAND STANFORD JUNIOR·Filed 1999·Granted Dec 17, 2002·268 cites·18 claims
- 0397US6669951B2Compositions and methods for enhancing drug delivery across and into epithelial tissuesCELLGATE INC·Filed 2001·Granted Dec 30, 2003·148 cites·88 claims
- 0496US6593292B1Compositions and methods for enhancing drug delivery across and into epithelial tissuesCELLGATE INC·Filed 2000·Granted Jul 15, 2003·163 cites·134 claims
- 0595US8246995B2Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cellsDAI HONGJIE·Filed 2006·Granted Aug 21, 2012·126 cites·15 claims
- 0695US7229961B2Compositions and methods for enhancing drug delivery across and into ocular tissuesCELLGATE INC·Filed 2002·Granted Jun 12, 2007·55 cites·36 claims
- 0795US6730293B1Compositions and methods for treating inflammatory diseases of the skinCELLGATE INC·Filed 2000·Granted May 4, 2004·83 cites·23 claims
- 0894US6759387B2Compositions and methods for enhancing drug delivery across and into epithelial tissuesCELLGATE INC·Filed 2002·Granted Jul 6, 2004·67 cites·31 claims
- 0994US6624189B2Byrostatin analogues, synthetic methods and usesUNIV LELAND STANFORD JUNIOR·Filed 2000·Granted Sep 23, 2003·48 cites·30 claims
- 1093US7585834B2Transporters comprising spaced arginine moietiesUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Sep 8, 2009·67 cites·33 claims
- 1192US8623833B2Compositions and methods for enhancing drug delivery across and into epithelial tissuesROTHBARD JONATHAN B·Filed 2010·Granted Jan 7, 2014·18 cites·25 claims
- 1292US8497385B2Bryostatin analogues, synthetic methods and usesWENDER PAUL A·Filed 2008·Granted Jul 30, 2013·12 cites·26 claims
- 1392US7256286B2Bryostatin analogues, synthetic methods and usesUNIV LELAND STANFORD JUNIOR·Filed 2003·Granted Aug 14, 2007·29 cites·19 claims
- 1492US7169814B2Guanidinium transport reagents and conjugatesCELLGATE INC·Filed 2002·Granted Jan 30, 2007·76 cites·32 claims
- 1590US8278264B2Compositions and methods for enhancing drug delivery across and into ocular tissuesROTHBARD JONATHAN B·Filed 2007·Granted Oct 2, 2012·7 cites·28 claims
- 1688US11746105B2Bryostatin compounds and methods of preparing the sameUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Sep 5, 2023·2 cites·3 claims
- 1788US8735609B2Bryostatin analogues, synthetic methods and usesUNIV LELAND STANFORD JUNIOR·Filed 2012·Granted May 27, 2014·5 cites·1 claims
- 1888US8729010B2Compositions and methods for enhancing drug delivery across and into ocular tissuesROTHBARD JONATHAN B·Filed 2012·Granted May 20, 2014·5 cites·20 claims
- 1987US8816122B2Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of useWENDER PAUL A·Filed 2010·Granted Aug 26, 2014·10 cites·7 claims
- 2087US8536378B2Prostratin and structural or functional analogs thereofWENDER PAUL A·Filed 2011·Granted Sep 17, 2013·4 cites·10 claims
- 2184US10654875B2Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe deliveryUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted May 19, 2020·2 cites·21 claims
- 2283US10947221B2Bryostatin compounds and methods of preparing the sameUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Mar 16, 2021·3 cites·22 claims
- 2383US8067632B2Process to produce prostratin and structural or functional analogs thereofWENDER PAUL A·Filed 2008·Granted Nov 29, 2011·5 cites·32 claims
- 2483US7939621B2Oligocarbonate molecular transportersIBM·Filed 2009·Granted May 10, 2011·7 cites·25 claims
- 2579US7232842B2Kinase inhibitors and associated pharmaceutical compositions and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2004·Granted Jun 19, 2007·9 cites·19 claims
- 2676US12435071B2Bryostatin compounds and methods of preparing the sameUNIV LELAND STANFORD JUNIOR·Filed 2023·Granted Oct 7, 2025·0 cites·7 claims
- 2775US7151116B2Apoptolidin analogs and derivatives for inducing apoptosis in transformed cellsUNIV LELAND STANFORD JUNIOR·Filed 2004·Granted Dec 19, 2006·9 cites·56 claims
- 2875US7067698B2Bi-directional synthesis of oligoguanidine transport agentsUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Jun 27, 2006·4 cites·30 claims
- 2973US8653238B2Compositions and methods for transport of molecules with enhanced release properties across biological barriersWENDER PAUL A·Filed 2007·Granted Feb 18, 2014·1 cites·14 claims
- 3067US2025177559A1Branched lipid charge-altering releasable transporters for nucleic acid deliveryUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 3166US10961263B2Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe deliveryUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Mar 30, 2021·0 cites·14 claims
- 3266US2024277854A1Immolative cell-penetrating complexes for nucleic acid delivery to the lungUNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 3366US2024277870A1Immolative cell-penetrating complexes for nucleic acid deliveryUNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 3464US2025381276A1Small molecule conjugated charge-altering releasable transporters for nucleic acid deliveryUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 3563US2010280262A1Bryostatin analogues, synthetic methods and usesWENDER PAUL A·Filed 2008·Application pending·0 cites
- 3662US2010081618A1Transporters Comprising Spaced Arginine MoietiesWENDER PAUL A·Filed 2009·Application pending·0 cites
- 3761US2011160146A1Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug ResistanceNAT INST OF HEALTH NIH·Filed 2009·Application pending·0 cites
- 3860US2007173436A1Compositions and methods for enhancing drug delivery across and into epithelial tissuesCELLGATE INC·Filed 2006·Application pending·0 cites
- 3960US2006111274A1Methods and compositions for enhancing transport across biological membranesUNIV LELAND STANFORD JUNIOR·Filed 2006·Application pending·0 cites
- 4059US9902957B2Amphipathic co-oligomers for the delivery of siRNACOOLEY CHRISTINA BARNES·Filed 2012·Granted Feb 27, 2018·1 cites·33 claims
- 4159US2014213532A1Compositions and methods for enhancing drug delivery across and into epithelial tissuesKAI PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4258US2012225826A1Transporters Comprising Spaced Arginine MoietiesWENDER PAUL A·Filed 2011·Application pending·0 cites
- 4357US2024132460A1Synthesis of tigilanol tiglate and analogs thereofUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 4456US2004186045A1Compositions and methods for enhancing drug delivery across and into epithelial tissuesCELLGATE INC A DELAWARE CORP·Filed 2003·Application pending·0 cites
- 4555US2003162719A1Method and composition for enhancing transport across biological membranesFiled 2003·Application pending·0 cites
- 4654US12215341B2Hybrid immolative cell-penetrating complexes for nucleic acid deliveryUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Feb 4, 2025·0 cites·15 claims
- 4754US2007270485A1Byrostatin analogues, synthetic methods and usesUNIV LELAND STANFORD JUNIOR·Filed 2007·Application pending·0 cites
- 4853US2002131965A1Method for enhancing transport across biological membranesFiled 2001·Application pending·0 cites
- 4952US11931416B2Immolative cell-penetrating complexes for nucleic acid delivery to the lungUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Mar 19, 2024·0 cites·13 claims
- 5052US8795734B2Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cellsDAI HONGJIE·Filed 2012·Granted Aug 5, 2014·0 cites·18 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Paul Wender files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →